Scientifically this type of a 'trial' would be worthless. What if patients who are col24a1 WT naturally progress more slowly than those who are variant. Then the WT patients would do better than variant regardless of treatment (Blarca, MAb, donepezil, KoolAid).
Market Data 
Markets 
AI
